Literature DB >> 28471820

Prevalence of intestinal complications in inflammatory bowel disease: a comparison between paediatric-onset and adult-onset patients.

Denise Herzog1, Nicolas Fournier, Patrick Buehr, Vanessa Rueger, Rebekka Koller, Klaas Heyland, Andreas Nydegger, Christian P Braegger.   

Abstract

INTRODUCTION: Intestinal complications in inflammatory bowel disease indicate active inflammation and typically result in the intensification of therapy. AIM: To analyse whether the rates of intestinal complications were associated with age at disease onset. PATIENTS AND METHODS: Data from 1506 individuals with Crohn's disease (CD) and 1201 individuals with ulcerative colitis (UC) were obtained from the Swiss inflammatory bowel disease cohort study database, classified into groups on the basis of age at diagnosis (<10, <17, <40 and >40 years of age), and retrospectively analysed.
RESULTS: In CD patients, the rates of stricturing (29.1-36.2%), abdominal penetrating disease (11.9-18.2%), resectional surgery (17.9-29.8%) and perianal disease (14.7-34.0%) were correlated with disease duration, but not age at diagnosis. However, paediatric-onset CD was associated with higher rates of multiple, rectal and anal strictures and earlier colon surgery. In addition, perianal disease occurred earlier, required earlier surgical intervention, and was more often combined with stricturing and penetrating disease. Finally, anal fissures were more prevalent among younger patients. In UC patients, the rates of progression or extension of disease (0-25.8%) and colectomy (3.0-8.7%) were dependent on disease duration, but not age at disease onset. Paediatric-onset disease was associated with a higher rate of extensive colitis at diagnosis and earlier progression or extension of disease, and nonsurgically treated patients with the youngest ages at onset more frequently required antitumour necrosis factor-α treatments.
CONCLUSION: The higher rates of intestinal complications, including those of the small and large bowel and in the anal region, in paediatric-onset CD patients point towards a level of inflammation that is more difficult to control. Similar findings were also evident in UC patients.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28471820     DOI: 10.1097/MEG.0000000000000896

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  7 in total

1.  Symptoms among emerging adults with inflammatory bowel disease: a descriptive study.

Authors:  Kendra Kamp; Sharon Dudley-Brown; Margaret Heitkemper; Gwen Wyatt; Barbara Given
Journal:  Res Nurs Health       Date:  2019-10-10       Impact factor: 2.228

2.  MRI reveals different Crohn's disease phenotypes in children and adults.

Authors:  Francesca Maccioni; Davide Bencardino; Valeria Buonocore; Fabrizio Mazzamurro; Franca Viola; Salvatore Oliva; Piero Vernia; Manuela Merli; Anna Rita Vestri; Carlo Catalano; Salvatore Cucchiara
Journal:  Eur Radiol       Date:  2019-02-07       Impact factor: 5.315

3.  Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases.

Authors:  Laura Bianchi; Federica Gaiani; Francesca Vincenzi; Stefano Kayali; Francesco Di Mario; Gioacchino Leandro; Gian Luigi De' Angelis; Claudio Ruberto
Journal:  Acta Biomed       Date:  2018-12-17

4.  A polymeric diet rich in transforming growth factor beta 2 does not reduce inflammation in chronic 2,4,6-trinitrobenzene sulfonic acid colitis in pre-pubertal rats.

Authors:  Claire Dupont-Lucas; Rachel Marion-Letellier; Mathilde Pala; Charlène Guerin; Asma Amamou; Marine Jarbeau; Christine Bôle-Feysot; Lionel Nicol; Amelyne David; Moutaz Aziz; Elodie Colasse; Céline Savoye-Collet; Guillaume Savoye
Journal:  BMC Gastroenterol       Date:  2020-12-10       Impact factor: 3.067

5.  A Validated Prognostic Model and Nomogram to Predict Early-Onset Complications Leading to Surgery in Patients With Crohn's Disease.

Authors:  Jiayin Yao; Yi Jiang; Jia Ke; Yi Lu; Jun Hu; Min Zhi
Journal:  Dis Colon Rectum       Date:  2021-06-01       Impact factor: 4.585

6.  Factors associated with poor compliance amongst hospitalized, predominantly adolescent pediatric Crohn's disease patients.

Authors:  Nathaniel A Cohen; Dejan M Micic; Atsushi Sakuraba
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709

7.  NADPH oxidase 4 is protective and not fibrogenic in intestinal inflammation.

Authors:  Emily Stenke; Gabriella Aviello; Ashish Singh; Sean Martin; Des Winter; Brian Sweeney; Michael McDermott; Billy Bourke; Seamus Hussey; Ulla G Knaus
Journal:  Redox Biol       Date:  2020-10-07       Impact factor: 11.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.